Teleflex Incorporated (TFX) Valuation
Historical valuation analysis based on 1279 data points (2021-09-14 to 2026-10-16)
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, ma...
Teleflex Incorporated (TFX) currently trades at a P/E ratio of 28.21 (historical range: 19.28–52.62, median: 31.19), placing it at the 35th percentile — below its historical average, P/S ratio of 3.39 (range: 1.41–6.87, 43th percentile — near its historical average), EV/EBITDA of 39.63 (range: 17.45–650.80, 95th percentile).
Over the historical period (2021-09-14 to 2026-10-16), Teleflex Incorporated's P/E ratio has expanded by 22% over the observed period (from an average of 29.6 to 36.1).
Teleflex Incorporated trades above its historical valuation range, with most metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 28.21 | 31.19 | 35th | below its historical average |
| P/S Ratio | 3.39 | 3.52 | 43th | near its historical average |
| EV/EBITDA | 39.63 | 26.27 | 95th | expensive relative to its history |
| FCF Yield | 1.64% | 3.78% | 1th | expensive relative to its history |
Teleflex Incorporated (TFX) Valuation & P/E History
Teleflex Incorporated (TFX) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry currently trading at $130.43 with a market capitalization of $5.5 billion. This page provides historical valuation analysis for TFX based on 1279 data points covering 2021-09-14 to 2026-10-16. The P/E ratio of 28.21 is below the historical median of 31.19, placing TFX at the 35th percentile of its valuation range. The P/S ratio of 3.39 compares to a median of 3.52.
TFX Valuation Metrics & Historical Range
The valuation table above shows Teleflex Incorporated's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether TFX is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests TFX is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Teleflex Incorporated.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is TFX Overvalued or Undervalued?
Teleflex Incorporated trades above its historical valuation range, with most metrics above their median levels. The overall valuation percentile of 58 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive TFX is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full TFX analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.TFX trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.